With a personalized plan, including TRT, vitamin therapy, and peptide support and lifestyle changes at home, Matt has lost over 40 pounds, built lean muscle, and achieved his best health yet

Clinical trial, 48 weeks: Body weight: -24.2% average Fat loss: significant Lean muscle mass: PRESERVED Metabolic markers: dramatically improved Heres why this is different: Ozempic/Mounjaro = dual agonists (GLP-1 + GIP) Suppress appetite You eat less Lose weight but also muscle Retatrutide = adds glucagon receptor Suppresses appetite AND Activates fat burning directly Body uses fat for fuel instead of breaking down muscle Blood work improvements tracked in trials: Fasting glucose: normalized Triglycerides: -40% Inflammatory markers: reduced Insulin sensitivity: significantly improved The metabolic difference: Dual agonists: Force you to eat less (suffer through hunger, lose muscle) Retatrutide: Reprograms metabolism to PREFER burning fat (appetite controlled, muscle preserved) DEXA scans in the study confirmed: Fat mass dropped dramatically

The latest prescription drugs, like Zepbound, Wegovy and Saxenda are approved for chronic (long-term) weight loss and come as subcutaneous (under the skin) injections
The next day, sections were incubated with VECTASTAIN ABC (Vector Laboratories) and developed with DAB+ (Enzo Life Sciences)
Bouzidi, A., Magnifico, M
Common complaints and concerns No program is perfect, and IVIM has its share of legitimate complaints documented on the Better Business Bureau, ConsumerAffairs, and other platforms